Clinical Trial Update: Predictive Factors of Ranibizumab Treatment in Macular Edema With CRVO [NA]

View source ↗

Summary

This clinical trial update describes factors that may predict how patients with macular edema due to Central Retinal Vein Occlusion respond to ranibizumab treat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Retinal Vein Occlusion
• Macular Edema

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Mie University | Conditions: Central Retinal Vein Occlusion | NA | Status: UNKNOWN